Fortis Healthcare, Apollo Hospitals, Max, Medanta shares rise: Should investors buy after 30% cancer drug price cap?

Hospital stocks such as Fortis Healthcare, Apollo Hospitals, Max, and Medanta have rallied after the government capped trade margins on non-scheduled anti-cancer drugs at 30%. This move is expected to cut prices by 20-70% and save patients ₹2,500 crore annually. While earnings effects may be manageable, hospital margins could face pressure.